These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32434703)

  • 21. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study.
    Miller JL; Thylén I; Elayi SC; Etaee F; Fleming S; Czarapata MM; Lennie TA; Moser DK
    J Psychosom Res; 2019 May; 120():39-45. PubMed ID: 30929706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recipients' of implanted cardioverter-defibrillators actual and perceived adaptation: a review of the literature.
    Zayac S; Finch N
    J Am Acad Nurse Pract; 2009 Oct; 21(10):549-56. PubMed ID: 19796289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
    Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
    Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions of Singaporean patients living with implantable cardioverter defibrillators: an exploratory qualitative study.
    Ooi SL; Seah B; Wu VX; Koh KWL; Jiao N; He HG; Wang W
    Heart Lung; 2018; 47(4):329-336. PubMed ID: 29724613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient plus partner trial: A randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator.
    Dougherty CM; Thompson EA; Kudenchuk PJ
    Heart Rhythm; 2019 Mar; 16(3):453-459. PubMed ID: 30340060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived control and quality of life among recipients of implantable cardioverter defibrillator.
    Hammash M; McEvedy SM; Wright J; Cameron J; Miller J; Ski CF; Thompson DR; Biddle MJ; Wimsatt A; Schrader M; Smith RV; Chung ML; Moser DK
    Aust Crit Care; 2019 Sep; 32(5):383-390. PubMed ID: 30292645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.
    von Gunten S; Schaer BA; Yap SC; Szili-Torok T; Kühne M; Sticherling C; Osswald S; Theuns DA
    Europace; 2016 May; 18(5):710-7. PubMed ID: 26609076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.
    Rosenqvist M; Beyer T; Block M; den Dulk K; Minten J; Lindemans F
    Circulation; 1998 Aug; 98(7):663-70. PubMed ID: 9715859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.
    van Rees JB; Borleffs CJ; Thijssen J; de Bie MK; van Erven L; Cannegieter SC; Bax JJ; Schalij MJ
    Europace; 2012 Jan; 14(1):66-73. PubMed ID: 21920909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
    Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.
    Hauser RG; Hayes DL; Epstein AE; Cannom DS; Vlay SC; Song SL; Tyers GF
    Heart Rhythm; 2006 Jun; 3(6):640-4. PubMed ID: 16731462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in cognitive function over 12 months among patients with an implantable cardioverter-defibrillator.
    Kim J; Pressler SJ; Groh WJ
    J Cardiovasc Nurs; 2013; 28(6):E28-36. PubMed ID: 23907140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.
    Flemme I; Johansson I; Strömberg A
    J Clin Nurs; 2012 Feb; 21(3-4):311-21. PubMed ID: 21951323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death.
    Carroll SL; Arthur HM
    Int J Nurs Stud; 2010 Jul; 47(7):836-45. PubMed ID: 20064639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.